Imprimis Pharma (IMMY) Reports Q4 Revenues Above Estimates

March 8, 2018 4:05 PM

Note: EPS may not be comparable

Imprimis Pharma (NASDAQ: IMMY) reported Q4 revenue for the quarter came in at $7.3 million versus the consensus estimate of $6.86 million.

Notable Highlights:

For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.


Earnings Guidance